Razavi Journal of Medicine

Razavi Journal of Medicine

Comparison of Systemic Inflammatory Response Markers Derived from Complete Blood Count between Women with Preeclampsia and Healthy Pregnant Women

Document Type : Original Article

Authors
1 Innovative Medical Research Center, MMS.C., Islamic Azad ‎University, Mashhad, Iran
2 Department of obstetrics and gynecology, MMS.C., Islamic Azad University, Mashhad, Iran
Abstract
Background: Preeclampsia is a significant pregnancy complication with an underlying inflammatory basis, typically occurring after the 20th week of gestation and associated with increased maternal and fetal risks. Identifying simple and effective markers for its prediction and monitoring can play an important role in early diagnosis and effective management of the condition.
 
Objectives: This study aimed to compare systemic inflammatory response markers derived from complete blood count between women with preeclampsia and normotensive pregnant women.
 
Methods: In this case-control study, 324 pregnant women, including 162 with preeclampsia and 162 healthy pregnant women, were evaluated. The CBC indices were calculated from the first blood sample obtained at hospital admission and compared between the two groups and between the subgroups of non-severe and severe preeclampsia. Statistical analyses were applied to examine correlations by using SPSS version 20.
 
Results: This study demonstrated statistically significant differences in NLR, PLR, and SII indices between women with preeclampsia and healthy pregnant women, whereas the MLR index did not differ significantly. In the comparison between non-severe and severe preeclampsia subgroups, only NLR and MLR showed statistically significant differences.
 
Conclusion: The findings of this study suggest that specific inflammatory indices derived from complete blood count may play an important role in the diagnosis and assessment of preeclampsia severity. These indices are simple, accessible, and cost-effective, and can serve as complementary tools alongside standard clinical and laboratory criteria to support early diagnosis and optimal patient management.
Keywords

Acknowledgements: The authors would like to thank all the patients for their participation, the experts at the Research Centre of Mashhad Medical Sciences, Islamic Azad University, and all individuals who contributed to the completion of this study.

 

Availability of data and materials: All data generated or analyzed during this study are included in this published article.

 

Conflicts of interests: All authors declared that they have no competing interests.

 

Consent for publication: Not applicable.

 

Ethics approval and consent to participate: The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The Research Ethics Committee approved the study with ID number (IR.IAU.MSHD.REC.1402.161). Written informed consent was obtained from all participants included in the study.

 

Financial disclosure: No financial support was received for this study.

 

Author contributions: Conceptualization: ZM; Methodology and Formal analysis: ZM; Investigation and Data curation: RA and NJ; Writing – Original draft: RA, SM, and NJ; Writing – Review & Editing: ZM, RA, SM.

 

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1. Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631-44.
https://doi.org/10.1016/S0140-6736(10)60279-6
PMid:20598363
 
2. Wisner K. Gestational hypertension and preeclampsia. MCN: The American Journal of Maternal/Child Nursing. 2019;44(3):170.
https://doi.org/10.1097/NMC.0000000000000523
PMid:31033586
 
3. Redman CW, Sargent IL. Immunology of preeclampsia. American journal of reproductive immunology. 2010;63(6):534-43.
https://doi.org/10.1111/j.1600-0897.2010.00831.x
PMid:20331588
 
4. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology. 2013;28(4):225-33.
https://doi.org/10.1152/physiol.00006.2013
PMid:23817797 PMCid:PMC3742131
 
5. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. Journal of Leukocyte Biology. 2013;94(2):247-57.
https://doi.org/10.1189/jlb.1112603
PMid:23633414
 
6. Han L, Liu X, Li H, Zou J, Yang Z, Han J, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PloS one. 2014;9(12):e114488.
https://doi.org/10.1371/journal.pone.0114488
PMid:25464515 PMCid:PMC4252147
 
7. Kim MA, Han GH, Kwon JY, Kim YH. Clinical significance of platelet‐to‐lymphocyte ratio in women with preeclampsia. American Journal of Reproductive Immunology. 2018;80(1):e12973.
https://doi.org/10.1111/aji.12973
PMid:29781540
 
8. Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? The journal of maternal-fetal & neonatal medicine. 2019;32(9):1412-9.
https://doi.org/10.1080/14767058.2017.1410701
PMid:29179639
 
9. Serin S, Avcı F, Ercan O, Köstü B, Bakacak M, Kıran H. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of preeclampsia? Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2016;6(1):22-5.
https://doi.org/10.1016/j.preghy.2016.01.005
PMid:26955767
 
10. Thombare D, Bhalerao A, Dixit P, Joshi S, Dapkekar P, Thombare Jr D. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Antenatal Women With Preeclampsia: A Case-Control Study. Cureus. 2023;15(6).
https://doi.org/10.7759/cureus.40338
 
11. Zhuang Y, Xiao Y, Bai R, Song Y, Lin Z, Yu Y, et al. The association of peripheral blood immunoinflammatory markers with PE and adverse outcomes in preeclampsia: a retrospective study. Journal of Inflammation Research. 2025:4359-66.
https://doi.org/10.2147/JIR.S504552
PMid:40162079 PMCid:PMC11954471
 
12. Khan JA, Ashraf A, Qureshi W, Fayaz F. Neutrophil-lymphocyte ratio as inflammatory marker for clinical prediction and disease severity evaluation of preeclampsia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 12(2):449.
https://doi.org/10.18203/2320-1770.ijrcog20230133
 
13. Toptas M, Asik H, Kalyoncuoglu M, Can E, Can MM. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio predictors for severity of preeclampsia? Journal of Clinical Gynecology and Obstetrics. 2016;5(1):27-31.
https://doi.org/10.14740/jcgo389w
 
14. Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Yidiz E, Ozbilgec S, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekologia polska. 2014;85(3).
https://doi.org/10.17772/gp/1713
 
15. Kang Q, Li W, Yu N, Fan L, Zhang Y, Sha M, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients. Pregnancy hypertension. 2020;20:111-8.
https://doi.org/10.1016/j.preghy.2020.03.009
PMid:32279029
 
16. Wang J, Zhu Q-W, Cheng X-Y, Liu J-y, Zhang L-l, Tao Y-M, et al. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. Journal of reproductive immunology. 2019;132:29-34
https://doi.org/10.1016/j.jri.2019.02.001
PMid:30861482